4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Jyong Biotech Ltd. (MENS) operates in the Biotechnology industry and is headquartered in New Taipei City, Taiwan with about 27 employees. Its market capitalization is roughly $174 million. In the fiscal year ended 2025-12-31, MENS reported $0M in revenue and ($5M) in net income.
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($2M) | ($3M) | ($3M) | — |
| Net Income | ($5M) | ($3M) | ($4M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $21M | $6M | $8M | $9M | — |
| Total Liabilities | $46M | $43M | $42M | $38M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MENS viewer.
About TickerBase · Data methodology & sources